CD83 and infection: HCMV-infected mature DCs treated with proteasome inhibitors had unchanged CD83 levels while non-treated HCMV-infected cells exhibited a significant decrease in surface CD83 levels within 12 h of infection, indicating that HCMV targets CD83 for proteasomal degradation.